drugset / Trial / NCT07154979
Oliceridine Dose for Tracheal Intubation Hemodynamic Elevation: Up-and-Down Trial
NaSingle-groupOpen-labelTreatment
Summary
This is a clinical trial using an up-and-down sequential design, aiming to investigate the median effective dose (ED50) and 95% effective dose (ED95) of oliceridine for inhibiting hyperdynamic responses induced by tracheal intubation during general anesthesia induction. The study will enroll patients undergoing elective tracheal intubation under general anesthesia, stratified into young (18-65 years) and elderly (≥65 years) groups. By dynamically adjusting oliceridine doses, the optimal induction dose in different age groups will be evaluated to provide reference for rational clinical medication.
Timeline
- Start
- 2025-09-04
- Primary completion
- 2025-09-11
- Completion
- 2025-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oliceridine | Other / unclassified | 40 ug/kg | Intravenous |
| Subject | Oliceridine | Other / unclassified | 45 ug/kg | Intravenous |
Indications
No indication recorded.